Covid-19 registration

COVID-19 DIAGNOSTICS

If you want to receive an invoice, please report it by phone.

Ladies and Gentlemen, due to the current epidemiological situation, we have introduced diagnostic tests to detect SARS-CoV-2 coronavirus antibodies.

In the diagnostics used in the course of COVID-19 disease, we offer:

Molecular test for the detection of SARC-CoV-2 virus (nasopharyngeal swab / pharyngeal swab) - compliant with the references of the World Health Organization (WHO) and the National Institute of Hygiene (PZH)

            Molecular tests show the highest sensitivity between 7-14 days after contact with SARS-CoV-2 virus, which coincides with the time of the first symptoms of infection. The molecular examination detects three genes of the SARS-CoV-2 virus: RdRP, E and the N gene. A positive test result indicates the presence of the virus. If the test result is borderline (doubtful, ambiguous) and the patient has symptoms of infection, it is classified as a probable case. The interpretation of the result must take into account the clinical condition of the patient.

Price: PLN 390

PWE ALSO CONDUCT RESEARCH OF EMPLOYEES - the possibility of testing larger groups of employees using the DRIVE THRU method at the Obornicka 262 clinic. Individual valuation. Contact: marketing@medpolonia.com.pl

 DUE TO THE WORSE SITUATION IN THE COUNTRY AND A VERY HIGH LOAD OF LABORATORIES MAY EXTEND THE WAITING TIME FOR THE RESULTS OF SARS-COV-2 ELEMENTS UP TO 48 HOURS!

Semi-quantitative test, SARS-CoV-2 coronavirus, IgG and IgM antibodies (blood test)

            The test enables the semi-quantitative in-vitro evaluation of human IgG (antibodies indicative of past infection) and IgM (antibodies in the early stage of infection) against SARS-CoV-2 in the serum. Antibody testing can confirm infection in patients with typical symptoms and when asymptomatic cases are suspected. The presence of IgG antibodies indicates a past infection, and the presence of IgA antibodies indicates the early stage of infection. The lack of antibodies does not exclude the presence of the disease. The interpretation of the result must take into account the clinical condition of the patient.

Price: PLN 300

Qualitative test, SARS-CoV-2 coronavirus, antigen

The test is helpful in the early diagnosis of SARS-CoV-2 infection. It is characterized by high diagnostic specificity, which, according to the literature and data obtained by the manufacturer, means that a positive result with a high probability indicates an active infection with SARS-CoV-2 virus. However, the limited sensitivity of the test means that a negative result does not exclude with 100% certainty an active disease. Due to the possibility of obtaining the result in just a few dozen minutes after taking the smear, the test is a quick diagnostic tool for active COVID-19 infection, thus enabling the quick implementation of existing procedures for dealing with COVID-19 patients. Verification of the positive result obtained in the Standard Q COVID-19 test is the result of a smear test recommended by WHO using the real time RT-PCR method. A negative result should be interpreted taking into account the clinical condition of the subject and the epidemiological interview, i.e. the analysis of the possibility of contact of the subject with people with confirmed disease. The test can be performed in people with symptoms suggesting the possibility of SARS-CoV-2 infection and in people suspecting the possibility of infection due to contact with a confirmed case of COVID-19 or staying in places with a high risk of infection (result on the day of the test). The result in Polish.

Price: PLN 170

Quantitative test, SARS-CoV-2 coronavirus, IgG antibodies, quantitative (blood test)

The test is used for the quantitative detection of IgG neutralizing antibodies (responsible for immunity) against the SARS-CoV-2 virus. IgG antibodies can be detected at least 11-14 days after the onset of the disease symptoms. We recommend anti-SARS-CoV-2 antibodies with the quantitative method as the first-choice test for people who want to test the level of IgG antibodies. Testing for IgG antibodies is especially recommended in people who have had an infection (also asymptomatic or mildly symptomatic). The test is designed to support the assessment of the patient's immune status by providing evidence of the presence of neutralizing IgG antibodies to SARS-CoV-2. The test results should not be used as a basis for the diagnosis or exclusion of SARS-CoV-2 infection, as well as informing about the stage of infection. The result in Polish.

Price: PLN 150

 In the event of resignation from the previously paid COVID-19 test in less than 24 hours, a handling fee of PLN 50 will be charged due to the costs of providing the service.

Positive / probable results of the above tests are reported directly from the laboratory to the sanitary and epidemiological station.

 TESTS ARE PERFORMED AT MEDPOLONIA OUTLET at ul. OBORNICKA 262.

 Sources: ALAB Laboratories, Diagnostics, Medical Laboratories

 

PERFORMANCE OF TESTS - INSTRUCTIONS FOR THE PATIENT

1. Contact with the MedPolonia facility at ul. Obornicka 262, phone: 61 66 43 300

  • Conducting an epidemiological interview
  • Setting a convenient date and time (Monday - Friday from 14:00)
  • Making a payment to a bank account:

SANTANDER BANK POLSKA S.A.
NO.95 1090 2590 0000 0001 2363 6912

Please send the payment confirmation to the following e-mail address: covid@medpolonia.pl

2. On the day of the examination:

  • Presentation an identity card for the purpose of data verification
  • The patient goes directly to entrance D (from the parking lot behind the clinic building-white tent)
  • You do not need to be  fasting for the test

3. Test results:

  • The patient receives an access code to the online test results
  • In case of a positive / probable test result, the laboratory sends a report to the appropriate sanitary and epidemiological station

 

https://gis.gov.pl/aktualnosci/komunikat-dot-aktualnej-sytuacji-epidemiologicznej-covid-19-nr-3-warszawa-17-kwietnia-2020-r-opracowano-na-podstawie-danych-who-ecdc-cdc/

 

Type of examination:

In the case of people who do not have a Pesel number, number and country of passport issue.
I AUTHORIZE DO NOT AUTHORIZE

Authorize:

Choose file File name...


To place my personal data in the database of MedPoloni Sp. z o.o., based in Poznań at ul. Obornicka 262, which will be their administrator, for their processing in accordance with the Regulation of the European Parliament and of the Council (EU) 2016/679 of April 27, 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46 / EC (General Data Protection Regulation). I hereby declare that I have been informed about the right to access my data and the possibility of requesting supplementation, updating, rectification and temporary or permanent suspension of their processing.
Partners